WebMD Health Corp. on Dec. 21 disclosed the final results of its tender offer to buy up to 2 million shares of its common stock at $55.00 per share.

WebMD accepted 2 million shares of its common stock for purchase, under the offer that expired Dec. 15, including all validly tendered odd lots, for $110 million. Based on the final count by American Stock Transfer & Trust Co., the depositary for the tender offer, about 14.9 million shares of WebMD Common Stock were properly tendered and neither withdrawn nor tendered conditionally by stockholders with conditions that were not met.

As per the depositary, after giving effect to the priority for an aggregate amount of about 915,000 odd lot shares, the final proration factor for the remaining tendered shares is about 7.74%. The depositary will issue payment for shares that were validly tendered and accepted for purchase, returning all other shares tendered.

Immediately following this purchase, WebMD will have about 37.6 million common stock shares outstanding, which includes about 900,000 unvested shares of restricted stock. The company expects to have about $980 million in cash and investments after the purchase.